KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease

Bibliographic Details
Published in:	Clinical and Molecular Hepatology
Format:	Article
Language:	English
Published:	Korean Association for the Study of the Liver 2013-12-01
Subjects:	Fatty liver Hepatic steatosis Guidelines Steatohepatitis
Online Access:	http://e-cmh.org/upload/pdf/cmh-19-325.pdf

Similar Items

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

SYSTEMATIC REVIEW WITH COMPARATIVE ANALYSIS OF RECOMMENDATIONS FOR THE DIAGNOSIS OF NONALCOHOLIC FATTY LIVER DISEASE
by: N.A. TOKTOGULOVA
Published: (2021-03-01)

Role of oxidative stress and glutathione system in the pathogenesis of nonalcoholic fatty liver disease
by: T. E. Promenasheva, et al.
Published: (2014-09-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025
by: Won Sohn, et al.
Published: (2025-02-01)

Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)

Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies
by: Farnush Bakhshimoghaddam, et al.
Published: (2024-11-01)

Biochemical assessment of metabolic associated fatty liver disease
by: Guerra-Ruiz Armando R., et al.
Published: (2021-03-01)

Biochemical and histological changes in two nonalcoholic fatty liver disease models of different severity
by: T. V. Brus, et al.
Published: (2024-07-01)

KASL clinical practice guidelines: management of hepatitis C
Published: (2016-03-01)

Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
by: Wasitha P. D. W. Thilakarathna, et al.
Published: (2024-02-01)

Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease
by: Raptis DD, et al.
Published: (2023-01-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)

Modern diagnostics of nonalcoholic fatty liver disease: noninvasive research methods
by: N. M. Palibroda
Published: (2016-08-01)

KASL clinical practice guidelines for management of autoimmune hepatitis 2022
Published: (2023-07-01)

Clinical Guidelines of the Russian Society for the Study of the Liver, Russian Gastroenterological Association, Russian Society for the Prevention of Non-Communicable Diseases, Russian Association of Endocrinologists, Russian Scientific Medical Society of Therapists, National Society of Preventive Cardiology, Russian Association of Gerontologists and Geriatricians on Non-Alcoholic Fatty Liver Disease
by: V. T. Ivashkin, et al.
Published: (2025-03-01)

CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
by: Ha Neul Kim, et al.
Published: (2023-03-01)

Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)

KASL clinical practice guidelines for management of chronic hepatitis B
Published: (2019-06-01)

KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Published: (2012-06-01)

KASL clinical practice guidelines: management of chronic hepatitis B
Published: (2016-03-01)

KASL clinical practice guidelines: Management of Hepatitis C
Published: (2014-06-01)

Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease
by: Yamei Duan, et al.
Published: (2022-05-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Adaptation of Clinical Practice Guideline for Assessment of Liver Fibrosis in Patients with Non Alcoholic Fatty Liver Disease in Isfahan Province
by: Sayed Mohammad Hosseeini, et al.
Published: (2024-08-01)

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease
by: Mi Na Kim, et al.
Published: (2024-09-01)

Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome
by: Ying-Hsiu Lin, et al.
Published: (2018-11-01)

Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population
by: Jieun Chung, et al.
Published: (2021-11-01)

Therapeutic Effects of Garlic on Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients: A Randomized Clinical Trial
by: Soleimani D, et al.
Published: (2020-07-01)

EXPRESSION OF TLR2, TLR3, TLR4 AND PROINFLAMMATORY TNF AND IL-6 CYTOKINES IN LIVER BIOPSIES OF NONALCOHOLIC FATTY LIVER DISEASE PATIENTS
by: A. V. Bogolyubova, et al.
Published: (2019-12-01)

KASL clinical practice guidelines for management of chronic hepatitis B
Published: (2022-04-01)

Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population
by: Eun-Ju Cho, et al.
Published: (2021-11-01)

Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)

Transient Elastography Role in the Diagnosis of Nonalcoholic Fatty Liver Disease
by: Yu.M. Stepanov, et al.
Published: (2016-04-01)

Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index for Classification of Patients with Steatotic Liver Disease
by: Akash Roy, et al.
Published: (2024-09-01)

Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary
by: Rosanna Villani, et al.
Published: (2023-03-01)

Recent Epidemiology of Nonalcoholic Fatty Liver Disease
by: Soumya Murag, et al.
Published: (2021-03-01)

Methodical approaches in experimental modelling of non-alcoholic fatty liver disease
by: N. V. Bivalkevich, et al.
Published: (2015-09-01)

Does vitamin E improve the outcomes of pediatric nonalcoholic fatty liver disease? A systematic review and meta-analysis
by: Ahmed A. Sarkhy, et al.
Published: (2014-01-01)

The validity of serum autotaxin as a predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease
by: Muhammad Abdel-Gawad, et al.
Published: (2023-10-01)